Mario Lobell

1.9k total citations
32 papers, 1.4k citations indexed

About

Mario Lobell is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Mario Lobell has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Computational Theory and Mathematics. Recurrent topics in Mario Lobell's work include Computational Drug Discovery Methods (7 papers), Analytical Chemistry and Chromatography (6 papers) and Protein Structure and Dynamics (4 papers). Mario Lobell is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Analytical Chemistry and Chromatography (6 papers) and Protein Structure and Dynamics (4 papers). Mario Lobell collaborates with scholars based in Germany, United Kingdom and United States. Mario Lobell's co-authors include Alexander Hillisch, David H. G. Crout, Manfred Schneider, Andreas H. Göller, Lloyd W. Ruddock, Heli I. Alanen, Kirsi E.H. Salo, László Molnár, György M. Keserű and Tobias Wunberg and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Mario Lobell

31 papers receiving 1.4k citations

Peers

Countries citing papers authored by Mario Lobell

Since Specialization

Citations

This map shows the geographic impact of Mario Lobell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Lobell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Lobell more than expected).

Fields of papers citing papers by Mario Lobell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Lobell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Lobell. The network helps show where Mario Lobell may publish in the future.

Co-authorship network of co-authors of Mario Lobell

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Lobell. A scholar is included among the top collaborators of Mario Lobell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Lobell. Mario Lobell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades 2020 ·Drug Discovery Today ·Andreas H. Göller, Lara Kuhnke, Floriane Montanari, (unknown), Sebastian Schneckener, Antonius ter Laak, Joerg Wichard, Mario Lobell, Alexander Hillisch	119
2	Evaluation of a new pharmacologic strategy for Nrf2 activation for retinal ischemia-reperfusion injury 2018 ·Elia J. Duh, Marcus Karlstetter, Zhenhua Xu, Junsong Gong, Hongkwan Cho, Jing Yang, Hartmut Schirok, (unknown), Mario Lobell, Martina Schaefer, (unknown), Khaled Nassar	1
3	Discovery of Rogaratinib (BAY 1163877): a pan‐FGFR Inhibitor 2018 ·ChemMedChem ·(unknown), Mario Lobell, (unknown), Dirk Brohm, Hartmut Schirok, Rolf Jautelat, Klemens Lustig, Ulf Bömer, (unknown), Mélanie Héroult, Sylvia Grünewald, Holger Hess‐Stumpp	40
4	Novel TIE‐2 inhibitor BAY‐826 displays in vivo efficacy in experimental syngeneic murine glioma models 2016 ·Journal of Neurochemistry ·Hannah Schneider, Emese Szabó, Raquel A. C. Machado, Angela Broggini‐Tenzer, Alexander M. Walter, Mario Lobell, (unknown), (unknown), Sylvia Grünewald, Michael Weller	20
5	A study on the trastuzumab conjugation at tyrosine using diazonium salts 2015 ·RSC Advances ·Nils Griebenow, Simone Greven, Mario Lobell, (unknown), Stefan Bräse	10
6	Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology To Improve in Silico pK_a Prediction 2014 ·Journal of Chemical Information and Modeling ·Robert Fraczkiewicz, Mario Lobell, Andreas H. Göller, (unknown), (unknown), Robert D. Clark, Alexander Hillisch	78
7	Abstract 1739: Preclinical profile of BAY 1163877 - a selective pan-FGFR inhibitor in phase 1 clinical trial 2014 ·Cancer Research ·Mélanie Héroult, Peter Ellinghaus, (unknown), Dirk Brohm, (unknown), (unknown), Ulf Boemer, Mario Lobell, (unknown), Matthias Ocker, Stuart Ince, Andrea Haegebarth, Rolf Jautelat, Holger Hess‐Stumpp, Michael Brands, Karl Ziegelbauer	9
8	Abstract 1026: Novel Tie2 inhibitor with in vivo efficacy in disseminated hematological tumor models in mice 2014 ·Cancer Research ·(unknown), Julia Schueler, Michael Haerter, (unknown), (unknown), Ulf Boemer, Stefan Kaulfuß, Alexander M. Walter, Mario Lobell, Ingo V. Hartung, Bernd Buchmann, (unknown), Holger Hess‐Stumpp, Karl Ziegelbauer	1
9	CypScore: Quantitative Prediction of Reactivity toward Cytochromes P450 Based on Semiempirical Molecular Orbital Theory 2009 ·ChemMedChem ·Matthias Hennemann, (unknown), Mario Lobell, Jörg Keldenich, Alexander Hillisch, Timothy Clark, Andreas H. Göller	57
10	Design and Synthesis of Potent and Selective Azaindole‐Based Rho Kinase (ROCK) Inhibitors 2008 ·ChemMedChem ·Hartmut Schirok, Raimund Kast, Santiago Figueroa‐Pérez, (unknown), Mark Jean Gnoth, Achim Feurer, Heike Heckroth, (unknown), Holger Paulsen, (unknown), Joachim Hütter, Mario Lobell, Klaus Münter, (unknown), Heimo Ehmke, Dieter Lang, Martin Radtke, Joachim Mittendorf, Johannes‐Peter Stasch	35
11	Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase 2007 ·British Journal of Pharmacology ·R. Kast, Hartmut Schirok, Santiago Figueroa‐Pérez, Joachim Mittendorf, Mark Jean Gnoth, Heiner Apeler, (unknown), Jürgen K. Franz, (unknown), Joachim Hütter, Mario Lobell, Katharina Zimmermann, Klaus Münter, (unknown), Heimo Ehmke, J.-P. Stasch	56
12	Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits 2006 ·Drug Discovery Today ·Tobias Wunberg, Martin Hendrix, Alexander Hillisch, Mario Lobell, Heinrich Meier, Carsten Schmeck, Hanno Wild, Berthold Hinzen	114
13	In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits 2006 ·ChemMedChem ·Mario Lobell, Martin Hendrix, Berthold Hinzen, Jörg Keldenich, Heinrich Meier, Carsten Schmeck, (unknown), Tobias Wunberg, Alexander Hillisch	81
14	Molecular Characterization of the Principal Substrate Binding Site of the Ubiquitous Folding Catalyst Protein Disulfide Isomerase 2004 ·Journal of Biological Chemistry ·(unknown), Peter Klappa, Mario Lobell, Richard A. Williamson, Lee J. Byrne, Heli I. Alanen, Kirsi E.H. Salo, Kari I. Kivirikko, Robert B. Freedman, Lloyd W. Ruddock	137
15	Recent Advances in the Prediction of Blood–Brain Partitioning from Molecular Structure 2003 ·Journal of Pharmaceutical Sciences ·Mario Lobell, László Molnár, György M. Keserű	83
16	A Conserved Arginine Plays a Role in the Catalytic Cycle of the Protein Disulphide Isomerases 2003 ·Journal of Molecular Biology ·Anna–Kaisa Lappi, Marc F. Lensink, Heli I. Alanen, Kirsi E.H. Salo, Mario Lobell, André H. Juffer, Lloyd W. Ruddock	109
17	In silico prediction of aqueous solubility, human plasma protein binding and volume of distribution of compounds from calculated pKa and AlogP98 values 2003 ·Molecular Diversity ·Mario Lobell, (unknown)	86
18	Stereochemistry of the decarboxylation of glyoxylic acid by yeast pyruvate decarboxylase 2000 ·Journal of the Chemical Society Perkin Transactions 1 ·(unknown), Mario Lobell, Stephen Bornemann, David H. G. Crout	1
19	Cyclodextrin-piroxicam Inclusion Complexes: Analysis by Mass Spectrometry and Molecular Modelling 1997 ·International Journal of Mass Spectrometry and Ion Processes ·(unknown), (unknown), (unknown), (unknown), Mario Lobell, (unknown)	3
20	New insight into the pyruvate decarboxylase-catalysed formation of lactaldehyde from H–D exchange experiments: a ‘water proof’ active site 1996 ·Journal of the Chemical Society Perkin Transactions 1 ·Mario Lobell, David H. G. Crout	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact